The SENSE trial: etravirine shows lower prevalence and severity of neuropsychiatric adverse events compared to efavirenz in treatment-naïve patients
Abstract
Publication Date:
2010
Iris type:
1.5 Abstract in rivista
List of contributors:
Stellbrink, Hj; Rugina, S; Zagler, C; Esser, S; Castagna, A; Gazzard, B; Hill, A; van Delft, Y; Marks, S
Published in: